Plasmodium falciparum Isolates Carrying pf k13 Polymorphisms Harbor the SVMNT Allele of pfcrt in Northwestern Indonesia
Author(s) -
Inke Nadia Diniyanti Lubis,
Hendri Wijaya,
Munar Lubis,
Chairuddin P. Lubis,
Khalid B. Beshir,
Colin J. Sutherland
Publication year - 2020
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02539-19
Subject(s) - artemisinin , plasmodium falciparum , malaria , biology , virology , allele , regimen , genetics , medicine , gene , immunology
Artemisinin-based combination therapy (ACT) is the first-line antimalarial regimen in Indonesia. Susceptibility ofPlasmodium falciparum to artemisinin is falling in the Greater Mekong subregion, but it is not known whether the efficacy of current combinations is also threatened in nearby Sumatera. We evaluated the genetic locipfcrt, pfmdr1 , andpfk13 , considered to be under selection by artemisinin combination therapy, among 404P. falciparum infections identified by PCR detection in a cross-sectional survey of 3,731 residents of three regencies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom